跳转至内容
Merck
CN

91462

Sigma-Aldrich

Kollisolv® PEG E 300

别名:

聚（乙二醇）, Lutrol E 300, Macrogol 300, 聚乙二醇 300, PEG

登录查看公司和协议定价

关于此项目

线性分子式:
H(OCH2CH2)nOH
CAS Number:
25322-68-3
MDL编号:
MFCD00081839
UNSPSC代码:
12352104
NACRES:
NA.25

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

表单

liquid

质量水平

100

分子量

average Mw 285-315 g/mol (from OH-value (56100*2)/OHZ)

杂质

reducing substances, complies
≤0.1% sulfated ash
≤0.25% ethylene glycol and diethylene glycol (sum)
≤1 ppm ethylene oxide
≤1 ppm lead (verified on random samples only)
≤1.0% water
≤10 ppm dioxan
≤15 ppm formaldehyde
≤5 ppm heavy metals (verified on random samples only)
0.5 g acetic acid (per 100 g)
620 ppm ethylene oxide

pH值（酸碱度）

4.5-7.0 (50 g/L)

粘度

80-105 mPa.s(20 °C) (5.4-6.4 CS (98.9°C))

羟基值

340‑394 mg KOH/g

溶解性

H2O: 10%, clear, colorless

适用性

complies for acidity or alkalinity

SMILES字符串

C(CO)O

InChI

1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2

InChI key

LYCAIKOWRPUZTN-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

应用

Kollisolv 聚乙二醇在制药工业中用作增稠剂和凝胶粘合剂。
该研究级产品仅用于研究和开发。

其他说明

PEG E 级的 Kollisolv 是具有不同分子量的聚乙二醇（聚乙二醇）。

法律信息

Kollisolv is a registered trademark of BASF

储存分类代码

10 - Combustible liquids

WGK

WGK 1

闪点(°F)

428.0 °F - closed cup

闪点(°C)

220.00 °C - closed cup

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCN1944
BCCN1946
BCCJ8948
BCCG6761
BCCF4164

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Scott N Furlan et al.
Science translational medicine, 7(315), 315ra191-315ra191 (2015-11-27)
Graft-versus-host disease (GVHD) is the most common complication of hematopoietic stem cell transplant (HCT). However, our understanding of the molecular pathways that cause this disease remains incomplete, leading to inadequate treatment strategies. To address this, we measured the gene expression
Matthew A Ingersoll et al.
Science advances, 6(49) (2020-12-04)
Hearing loss caused by noise, aging, antibiotics, and chemotherapy affects 10% of the world population, yet there are no Food and Drug Administration (FDA)-approved drugs to prevent it. Here, we screened 162 small-molecule kinase-specific inhibitors for reduction of cisplatin toxicity
I L Konorova et al.
Patologicheskaia fiziologiia i eksperimental'naia terapiia, (4)(4), 7-9 (1991-07-01)
The search for antiaggregatory compounds is undertaken, as a rule, under in vitro conditions which do not reflect the dynamics of the real process. The present work deals with study of the peculiarities of the development of the collagen induced
P I Polimeni et al.
Journal of cardiovascular pharmacology, 14(3), 374-380 (1989-09-01)
The acute hemodynamic effects of an intravenously (i.v.) injected poly(ethylene oxide), Polyox WSR N-60K (dose 50 mg/kg), were studied in the open-chest rat anesthetized with sodium pentobarbital. The injectate is one of four drag-reducing polymers known to augment in vitro
D D Smyth et al.
Cardiovascular drugs and therapy, 4(1), 297-300 (1990-02-01)
Previous studies have demonstrated that Separan AP-30, a drag-reducing polymer, significantly decreased the formation of atherosclerotic plaques in rabbits fed a high-cholesterol diet. Furthermore, Separan AP-273, a polymer similar to but longer than Separan AP-30, markedly increased cardiac output in

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持